Epivax Oncology

EpiVax Oncology Inc. is a spin-off company of EpiVax. EpiVax Oncology leverages the world-class excellence in computational immunology, genomics, and vaccine design that EpiVax has established over the past 20 years. Nine out of the top 12 global biopharmaceutical companies use EpiVax tools to design novel biologics and vaccines. EpiVax Oncology is a precision cancer immunotherapy company developing personalized therapeutic vaccines targeting neoantigens. EpiVax Oncology's therapeutic vaccines are customized and specifically designed for each patient’s tumor, utilizing advancements in next-generation sequencing and computational immunology.